| Name | Title | Contact Details |
|---|
yellow.ai is a leading CX Automation Platform helping businesses to build chatbots and voicebots to automate support, sales, marketing, HR, ITSM, in 100+ languages, across 35+ channels
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Sincera provides data management solutions and services to empower Enterprises to leverage data for maximum value. Request a demo today.
Dr. Al Sears is Americas #1 Anti-Aging MD. Sign up now to receive his FREE daily email newsletter - Doctors House Call!
Discover the world of ALEXIS and shop the latest collections. Subscribe to hear about our latest arrivals, exclusive sales, and events.